{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:05:00Z","timestamp":1790510700318,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.cyto.2012.06.008","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T20:38:15Z","timestamp":1341261495000},"page":"114-121","source":"Crossref","is-referenced-by-count":65,"title":["Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-\u03baB activation on endothelial cell"],"prefix":"10.1016","volume":"60","author":[{"given":"Xu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2012.06.008_b0125","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cyto.2012.06.008_b0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"Schouten","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2012.06.008_b0025","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2012.06.008_b0030","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2012.06.008_b0035","doi-asserted-by":"crossref","first-page":"L622","DOI":"10.1152\/ajplung.00477.2005","article-title":"NF-kappa B activation as a pathological mechanism of septic shock and inflammation","volume":"290","author":"Liu","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cyto.2012.06.008_b0040","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0045","doi-asserted-by":"crossref","first-page":"26796","DOI":"10.1016\/S0021-9258(18)47089-5","article-title":"Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator","volume":"269","author":"Barrow","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.06.008_b0050","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-6147(00)89022-7","article-title":"Therapeutic uses of heparin beyond its traditional role as an anticoagulant","volume":"16","author":"Tyrell","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cyto.2012.06.008_b0055","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/01.CCM.0000220764.10155.03","article-title":"Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats","volume":"34","author":"Harada","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00024382-199607000-00010","article-title":"A novel nonanticoagulant heparin prevents vascular endothelial cell dysfunction during hyperdynamic sepsis","volume":"6","author":"Morrison","year":"1996","journal-title":"Shock"},{"issue":"3 Suppl","key":"10.1016\/j.cyto.2012.06.008_b0065","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cyto.2012.06.008_b0070","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000542-200612000-00020","article-title":"Heme oxygenase 1, nuclear factor E2-related factor 2, and nuclear factor kappaB are involved in hemin inhibition of type 2 cationic amino acid transporter expression and l-arginine transport in stimulated macrophages","volume":"105","author":"Tsai","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cyto.2012.06.008_b0075","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJMp020096","article-title":"Treating sepsis","volume":"347","author":"Wenzel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0080","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood-2002-06-1887","article-title":"The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome","volume":"101","author":"Aird","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2012.06.008_b0085","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM200103083441009","article-title":"Severe sepsis \u2013 a new treatment with both anticoagulant and antiinflammatory properties","volume":"344","author":"Matthay","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0095","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00134-004-2291-8","article-title":"Coagulation in sepsis","volume":"30","author":"Amaral","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cyto.2012.06.008_b0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cyto.2012.06.008_b0105","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00011-004-1291-z","article-title":"Drotrecogin alfa(activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis","volume":"53","author":"Brueckmann","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.cyto.2012.06.008_b0110","doi-asserted-by":"crossref","first-page":"H2084","DOI":"10.1152\/ajpheart.2000.278.6.H2084","article-title":"Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury","volume":"278","author":"Thourani","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cyto.2012.06.008_b0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejphar.2003.08.016","article-title":"Effect of enoxaparin on high glucose-induced activation of endothelial cells","volume":"477","author":"Manduteanu","year":"2003","journal-title":"Eur J Pharmacol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612002530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612002530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T02:18:28Z","timestamp":1642645108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612002530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1043466612002530"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.06.008","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}